Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedPublication entry added under Publications summarizing a new article on the analytical and clinical performance of the CLDN18.2 assay in SPOTLIGHT and GLOW, including author names and journal details. This enriches the study file with related publication information.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added to the study's ID Numbers, signaling NIH funding support for the trial.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This is a metadata update to the page’s version label and does not modify the study content.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update appears to be a minor metadata change and does not modify the study content visible to users.SummaryDifference0.0%

- Check62 days agoChange DetectedPublications section gained a new citation detailing a subgroup analysis of SPOTLIGHT and GLOW in Japanese CLDN18.2-positive gastric or GEJ adenocarcinoma (Yamaguchi K et al.). The entry includes the article title, Gastric Cancer, 2026, Epub May 7, and the DOI 10.1007/s10120-026-01738-7.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.0, indicating a page update.SummaryDifference0.0%

Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.